Qualifiyze — Transforming Supply Chain Compliance In Pharma
Tech DD on Audit Data and Application Platform Company
Qualifyze just raised $12 million in a round led by HV Capital and new investor HarbourVest Partners with participation from H14. Philipps & Byrne was on board by providing the Product and Technology Due Diligence. The Startup offers compliance solutions for the pharmaceutical industry. Their mission is to transform supply chain compliance in the healthcare industry in a sustainable, data-driven manner.
- Location: Frankfurt, Germany
- Business Context: Pharmaceutical Industry
- Tech Landscape: SaaS
- Round: 12 Million Dollar
Tech Due Diligence on Qualifyze’s Product and Tech Organization
Since its inception in 2019, Qualifyze has conducted audits on a multitude of suppliers.’ By effectively capturing audit data at scale and providing a comprehensive digital platform for end-to-end audit management, Qualifyze has already assisted over 1,000 pharmaceutical manufacturers in enhancing supply chain compliance and reducing supplier qualification expenses.
In the Tech Due Diligence, Philipps & Byrne scrutinized Qualifyze’s technological framework from every conceivable angle. This encompassed a holistic examination, spanning from the leadership landscape and the intricacies of product management to the dynamics within the team. Beyond that, we looked into the organizational structure, the architectural foundation underpinning the tech stack, the robustness of hosting and infrastructure, the software delivery and quality assurance processes, and of course, security and privacy.
The resulting report provided actionable recommendations to help Qualifyze on their ongoing journey of growth while also enhancing their tech and product organization for the future.
About Qualifyze
Since its inception in 2019, Qualifyze has been committed to supporting pharma companies with fast, flexible, and reliable supply chain compliance assessments. Qualifyze connects customers, suppliers, and auditors via their data and application platform. They capture and convert proprietary raw audit data to generate unique insights into supplier compliance levels across the supply chain and help their partners in healthcare track, monitor, and forecast quality and sustainability compliance efforts. Through this cloud-based platform, their customers can access and drill down into supplier compliance information at any time across multiple sites, shaping a new way to optimize supplier risk mitigation processes in a streamlined, cost-effective manner. With a global network of over 200 local expert auditors, 1,000+ pharma clients, and the world’s largest database of supplier compliance data from 2,000+ suppliers, Qualifyze is a leading provider of structured and analyzable GxP audit data resulting from onsite inspections in the pharmaceutical supply chain.
Visit: qualifyze.com
About HV Capital
Since 2000, HV Capital, formerly HV Holtzbrinck Ventures, has backed Internet and technology companies through various generations of funds and is one of the most successful and financially strongest early-stage and growth venture capitalists in Europe. HV’s funds have already invested in around 200 companies, including Zalando, Delivery Hero, FlixBus and SumUp. The total of all HV‘s funds amounts to €1.7 billion. The company supports startups with capital between €500,000 and €50 million. This makes HV Capital one of the few venture capitalists in Europe that can back startups through all growth phases.
Visit: hvcapital.com